The global medical device packaging market size was valued at USD 29.70 billion in 2024 and anticipated to calculate USD 60.76 billion by 2034, expanding at a 7.42% CAGR between 2024 and 2034.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | TTM |
| Total revenue | 3.25 B | 3.41 B | 3.54 B | 3.35 B | 3.24 B | 3.33 B | 5.08 B | 5.75 B | 17.40 B |
| YoY growth | −10.73% | −7.03% | −3.76% | −2.61% | −0.34% | −2.26% | 43.73% | 71.34% | |
| Cost of goods sold | −2.63 B | −2.72 B | −2.78 B | −2.70 B | −2.61 B | −2.68 B | −4.31 B | −4.76 B | −14.36 B |
| Gross profit | 622.00 M | 692.00 M | 754.00 M | 658.00 M | 627.00 M | 654.00 M | 770.00 M | 988.00 M | 3.04 B |
| YoY growth | −6.75% | 3.28% | 4.43% | 1.86% | 0.80% | −5.49% | 2.12% | 50.15% | |
| Operating expenses (excl. COGS) | −327.00 M | −355.00 M | −355.00 M | −343.00 M | −322.00 M | −330.00 M | −446.00 M | −477.00 M | −1.58 B |
| Operating income | 295.00 M | 337.00 M | 399.00 M | 315.00 M | 305.00 M | 324.00 M | 324.00 M | 511.00 M | 1.46 B |
| YoY growth | −14.49% | 3.37% | 8.42% | −0.63% | 3.39% | −3.86% | −18.80% | 62.22% | |
| Non-operating income (total) | −130.00 M | −107.00 M | −80.00 M | −79.00 M | −81.00 M | −87.00 M | −371.00 M | −202.00 M | −741.00 M |
| Pretax income | 165.00 M | 230.00 M | 318.00 M | 236.00 M | 224.00 M | 237.00 M | −47.00 M | 309.00 M | 723.00 M |
| YoY growth | −66.60% | 7.98% | 26.19% | 21.65% | 35.76% | 3.04% | −114.78% | 30.93% | |
| Equity in earnings | −1.00 M | −1.00 M | −1.00 M | 0 | 1.00 M | 0 | 2.00 M | 2.00 M | 5.00 M |
| Taxes | −28.00 M | −40.00 M | −56.00 M | −43.00 M | −58.00 M | −40.00 M | 6.00 M | −49.00 M | −141.00 M |
| Non-controlling/minority interest | −2.00 M | −2.00 M | −4.00 M | −2.00 M | −4.00 M | −1.00 M | 0 | 0 | −5.00 M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net income before discontinued operations | 134.00 M | 187.00 M | 257.00 M | 191.00 M | 163.00 M | 196.00 M | −39.00 M | 262.00 M | 582.00 M |
| Discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net income | 134.00 M | 187.00 M | 257.00 M | 191.00 M | 163.00 M | 196.00 M | −39.00 M | 262.00 M | 582.00 M |
| YoY growth | −70.81% | 5.65% | 42.78% | 25.66% | 21.64% | 4.81% | −115.18% | 37.17% | |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Preferred dividends | 1.00 M | 1.00 M | 1.00 M | 1.00 M | 0 | 0 | 0 | 0 | — |
| Diluted net income available to common stockholders | 133.00 M | 186.00 M | 256.00 M | 190.00 M | 163.00 M | 196.00 M | −39.00 M | 262.00 M | 582.00 M |
| Basic earnings per share (basic EPS) | 0.09 | 0.13 | 0.18 | 0.13 | 0.11 | 0.14 | −0.02 | 0.11 | 0.34 |
| YoY growth | −70.11% | 8.02% | 43.82% | 25.74% | 22.29% | 5.03% | −110.79% | −14.18% | |
| Diluted earnings per share (diluted EPS) | 0.09 | 0.13 | 0.18 | 0.13 | 0.11 | 0.14 | −0.02 | 0.11 | 0.34 |
| YoY growth | −69.91% | 8.39% | 43.53% | 25.45% | 21.97% | 4.88% | −110.82% | −13.98% | |
| Average basic shares outstanding | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 2.04 B | 2.31 B | — |
| Diluted shares outstanding | 1.44 B | 1.44 B | 1.44 B | 1.44 B | 1.45 B | 1.45 B | 2.04 B | 2.31 B | — |
| EBITDA | 441.00 M | 490.00 M | 546.00 M | 456.00 M | 431.00 M | 456.00 M | 640.00 M | 875.00 M | 2.40 B |
| YoY growth | −7.74% | 4.26% | 3.80% | −2.15% | −2.27% | −6.94% | 17.22% | 91.89% | |
| EBIT | 295.00 M | 337.00 M | 399.00 M | 315.00 M | 305.00 M | 324.00 M | 324.00 M | 511.00 M | 1.46 B |
| YoY growth | −14.49% | 3.37% | 8.42% | −0.63% | 3.39% | −3.86% | −18.80% | 62.22% | |
| Total operating expenses | −2.96 B | −3.07 B | −3.14 B | −3.04 B | −2.94 B | −3.01 B | −4.76 B | −5.23 B | −15.94 B |
The competitive landscape of the medical device packaging market is dominated by established industry giants such as Berry Global Inc., Amcor Limited, Mitsubishi Chemical Holdings Corporation, 3M COMPANY, CCL Industries Inc., Constantia Flexibles, Klöckner Pentaplast Group, Sonoco Products Company, Dupont De Nemours Oliver-Tolas, NIPRO, and Texchem-pack. These giants compete with upstart direct-to-consumer firms that use digital platforms to gain market share. Key competitive characteristics include product innovation, sustainable practices, and the ability to respond to changing consumer tastes.
Berry Global prioritises innovation and customisation to satisfy the changing needs of the medical device sector. The company invests substantially in R&D to provide cutting-edge packaging solutions that prioritise safety, sterility, and usability. Berry Global also prioritises collaboration with medical device makers to understand their individual needs and customise packaging solutions accordingly.
For Instance,
Amcor has adopted a global expansion plan to increase its footprint in the medical device packaging market. The company uses its large global network and manufacturing skills to provide a wide range of packaging solutions targeted to specific locations and customer segments.
For Instance,